Retrospective Analysis of Chest X-ray Severity Scoring System of COVID-19 Pneumonia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorOsijek University Hospital
About this trial
The research will be retrospective, and will include all patients who were admitted during 2020 and 2021 in the COVID-19 ICU of University Hospital Center Osijek due to pneumonia caused by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The association of chest x-ray infiltrate evolution with changes in laboratory inflammatory parameters and respiratory function parameters will be examined.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Pneumonia caused by SARS-CoV-2 virus
Admission to the ICU COVID-19 unit
Disqualifiers
None
Trial population
All patients treated in ICU COVID-19 with a diagnosis of pneumonia will be analyzed retrospectively.
Trial design
Design model
Case-control
Time perspective
Retrospective
Treatments tested in this trial
Chest X-ray
Diagnostic testRetrospective analysis of chest x-rays of patients with COVID-19
Treatment groups
200 Participants
are divided into 1 treatment groupGroup A: COVID-19 pneumonia patients1 intervention
Trial outcomes
Primary outcomes
1
Chest x-ray severity score
The influence of the dynamics of radiographic changes quantified by Brixia score on the outcome of COVID-19 patients will be examined
Time frame
21 days2
Inflammatory markers
The influence of serum levels of inflammatory parameters, and clinical and laboratory indicators of organic failure on chest x-ray severity score will be examined
Time frame
21 daysSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov